TNDM

SEC source: 0001438133-20-000086 · wf-form4_159130281060322.xml · derivative · entry 4

BERGER DAVID B · CIK 0001422126 · EVP, Chief Legal & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000

Underlying: Stock Option · 2,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Fifty percent (50%) of the underlying shares subject to the option vested on 12/1/2018, and the remaining shares vested in twelve (12) equal monthly installments thereafter.

F6 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

SEC source: 0001438133-20-000086 · wf-form4_159130281060322.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP, Chief Legal & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,566

F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2019.

F3 · price: The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $81.76 to $81.92. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

SEC source: 0001438133-20-000086 · wf-form4_159130281060322.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP, Chief Legal & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,566

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares of common stock received upon exercise of a stock option award.

SEC source: 0001438133-20-000071 · wf-form4_159079943722895.xml · derivative · entry 1

CAHILL EDWARD L · CIK 0001025665 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,892

Underlying: Common Stock · 1,892 shares

Expires not disclosed

F1 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F3 · derivative.exercise_date: Shares will vest on the one year anniversary of the grant date, subject to the terms of the 2013 Plan.

F3 · derivative.expiration_date: Shares will vest on the one year anniversary of the grant date, subject to the terms of the 2013 Plan.

SEC source: 0001438133-20-000074 · wf-form4_159079953803859.xml · derivative · entry 2

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,012

Underlying: Common Stock · 15,012 shares

Expires not disclosed

F1 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F4 · derivative.exercise_date: The option shall vest as to twenty-five percent (25%) of the underlying shares on the one year anniversary of the grant date, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

SEC source: 0001438133-20-000074 · wf-form4_159079953803859.xml · derivative · entry 1

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,504

Underlying: Common Stock · 6,504 shares

Expires not disclosed

F1 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F3 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F3 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

SEC source: 0001438133-20-000081 · wf-form4_159079990871134.xml · derivative · entry 1

Allen Dick · CIK 0001582779 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,892

Underlying: Common Stock · 1,892 shares

Expires not disclosed

F1 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F3 · derivative.exercise_date: Shares will vest on the one year anniversary of the grant date, subject to the terms of the 2013 Plan.

F3 · derivative.expiration_date: Shares will vest on the one year anniversary of the grant date, subject to the terms of the 2013 Plan.

SEC source: 0001438133-20-000080 · wf-form4_159079987497213.xml · derivative · entry 1

ROEDER DOUGLAS A · CIK 0001270735 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,892

Underlying: Common Stock · 1,892 shares

Expires not disclosed

F1 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F3 · derivative.exercise_date: Shares will vest on the one year anniversary of the grant date, subject to the terms of the 2013 Plan.

F3 · derivative.expiration_date: Shares will vest on the one year anniversary of the grant date, subject to the terms of the 2013 Plan.

SEC source: 0001438133-20-000079 · wf-form4_159079983658765.xml · derivative · entry 1

TWOMEY CHRISTOPHER J · CIK 0001238935 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,892

Underlying: Common Stock · 1,892 shares

Expires not disclosed

F1 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F3 · derivative.exercise_date: Shares will vest on the one year anniversary of the grant date, subject to the terms of the 2013 Plan.

F3 · derivative.expiration_date: Shares will vest on the one year anniversary of the grant date, subject to the terms of the 2013 Plan.

SEC source: 0001438133-20-000078 · wf-form4_159079978796508.xml · derivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP, Chief Legal & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,012

Underlying: Common Stock · 15,012 shares

Expires not disclosed

F1 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F4 · derivative.exercise_date: The option shall vest as to twenty-five percent (25%) of the underlying shares on the one year anniversary of the grant date, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

SEC source: 0001438133-20-000078 · wf-form4_159079978796508.xml · derivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP, Chief Legal & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,504

Underlying: Common Stock · 6,504 shares

Expires not disclosed

F1 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F3 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F3 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

SEC source: 0001438133-20-000077 · wf-form4_159079975986456.xml · derivative · entry 1

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,892

Underlying: Common Stock · 1,892 shares

Expires not disclosed

F1 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F3 · derivative.exercise_date: Shares will vest on the one year anniversary of the grant date, subject to the terms of the 2013 Plan.

F3 · derivative.expiration_date: Shares will vest on the one year anniversary of the grant date, subject to the terms of the 2013 Plan.

SEC source: 0001438133-20-000075 · wf-form4_159079961836822.xml · derivative · entry 2

Sheridan John F · CIK 0001365369 · PRESIDENT & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,272

Underlying: Common Stock · 30,272 shares

Expires not disclosed

F1 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F4 · derivative.exercise_date: The option shall vest as to twenty-five percent (25%) of the underlying shares on the one year anniversary of the grant date, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

SEC source: 0001438133-20-000075 · wf-form4_159079961836822.xml · derivative · entry 1

Sheridan John F · CIK 0001365369 · PRESIDENT & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,116

Underlying: Common Stock · 13,116 shares

Expires not disclosed

F1 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F3 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F3 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

SEC source: 0001438133-20-000076 · wf-form4_159079968772006.xml · derivative · entry 1

BLICKENSTAFF KIM D · CIK 0001238913 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,892

Underlying: Common Stock · 1,892 shares

Expires not disclosed

F1 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F3 · derivative.exercise_date: Shares will vest on the one year anniversary of the grant date, subject to the terms of the 2013 Plan.

F3 · derivative.expiration_date: Shares will vest on the one year anniversary of the grant date, subject to the terms of the 2013 Plan.

SEC source: 0001438133-20-000073 · wf-form4_159079950739711.xml · derivative · entry 2

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,012

Underlying: Common Stock · 15,012 shares

Expires not disclosed

F1 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F4 · derivative.exercise_date: The option shall vest as to twenty-five percent (25%) of the underlying shares on the one year anniversary of the grant date, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

SEC source: 0001438133-20-000073 · wf-form4_159079950739711.xml · derivative · entry 1

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,504

Underlying: Common Stock · 6,504 shares

Expires not disclosed

F1 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F3 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F3 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

SEC source: 0001438133-20-000072 · wf-form4_159079947054567.xml · derivative · entry 2

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,012

Underlying: Common Stock · 15,012 shares

Expires not disclosed

F1 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F4 · derivative.exercise_date: The option shall vest as to twenty-five percent (25%) of the underlying shares on the one year anniversary of the grant date, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

SEC source: 0001438133-20-000072 · wf-form4_159079947054567.xml · derivative · entry 1

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,504

Underlying: Common Stock · 6,504 shares

Expires not disclosed

F1 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F3 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F3 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

SEC source: 0001438133-20-000058 · wf-form4_158993499096663.xml · nonDerivative · entry 1

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,520

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 16, 2019 through May 15, 2020. This transaction is also exempt under Rule 16b-3(c).

SEC source: 0001438133-20-000061 · wf-form4_158993507883925.xml · nonDerivative · entry 1

Sheridan John F · CIK 0001365369 · PRESIDENT & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,756

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 16, 2019 through May 15, 2020. This transaction is also exempt under Rule 16b-3(c).

SEC source: 0001438133-20-000060 · wf-form4_158993504559084.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP, Chief Legal & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,566

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 16, 2019 through May 15, 2020. This transaction is also exempt under Rule 16b-3(c).

SEC source: 0001438133-20-000059 · wf-form4_158993501812795.xml · nonDerivative · entry 1

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,665

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 16, 2019 through May 15, 2020. This transaction is also exempt under Rule 16b-3(c).

SEC source: 0001438133-20-000057 · wf-form4_158993495580069.xml · nonDerivative · entry 1

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,256

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 16, 2019 through May 15, 2020. This transaction is also exempt under Rule 16b-3(c).

SEC source: 0001438133-20-000043 · wf-form4_158896940589613.xml · derivative · entry 4

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option shall vest as to fifty percent (50%) of the underlying shares on 12/01/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter.

F6 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

SEC source: 0001438133-20-000043 · wf-form4_158896940589613.xml · nonDerivative · entry 2

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,265

F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2020.

F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $90.00 to $90.145. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

SEC source: 0001438133-20-000043 · wf-form4_158896940589613.xml · nonDerivative · entry 1

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,265

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares of common stock received upon exercise of a stock option award.

SEC source: 0001438133-20-000045 · wf-form4_158896949182434.xml · nonDerivative · entry 3

Allen Dick · CIK 0001582779 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 1,000

F1 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 04, 2020.

F4 · ownership.nature: The securities are held by the Gammon Children's 2000 Trust FBO Jake Allen Gammon. The Reporting Person is co-trustee of the Gammon Children's 2000 Trust FBO Jake Allen Gammon and has shared voting and investment power over the securities held by the Gammon Children's 2000 Trust FBO Jake Allen Gammon and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by the Gammon Children's 2000 Trust FBO Jake Allen Gammon.

SEC source: 0001438133-20-000045 · wf-form4_158896949182434.xml · nonDerivative · entry 2

Allen Dick · CIK 0001582779 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote(s)

Disclosed balance after: 1,000

F1 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 04, 2020.

F3 · ownership.nature: The securities are held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon. The Reporting Person is co-trustee of the Gammon Children's 2000 Trust FBO Hannah Lee Gammon and has shared voting and investment power over the securities held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon.

SEC source: 0001438133-20-000045 · wf-form4_158896949182434.xml · nonDerivative · entry 1

Allen Dick · CIK 0001582779 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes)

Disclosed balance after: 7,526

F1 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 04, 2020.

F2 · ownership.nature: The securities are held by Allen Cornerstone Ventures L.P. The Reporting Person is the managing partner of Allen Cornerstone Ventures L.P. and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by Allen Cornerstone Ventures L.P., except to the extent of his proportionate pecuniary interest therein.

SEC source: 0001438133-20-000044 · wf-form4_158896945165455.xml · nonDerivative · entry 3

TWOMEY CHRISTOPHER J · CIK 0001238935 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 22,500

F1 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2020.

F6 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $90.00 and $90.010. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

F7 · ownership.nature: The securities are directly owned by Twomey Family Investments, LLC. The Reporting Person is co-manager of Twomey Family Investments, LLC and shares voting and investment power over the securities held by Twomey Family Investments, LLC and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such securities held by Twomey Family Investments, LLC, except to the extent of his proportionate pecuniary interest therein.

SEC source: 0001438133-20-000044 · wf-form4_158896945165455.xml · nonDerivative · entry 2

TWOMEY CHRISTOPHER J · CIK 0001238935 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 42,500

F4 · kind: The shares were given as a bona fide gift to the Chris and Rebecca Twomey Family Foundation at the San Diego Foundation.

F5 · price: The price per share reflects the average of the high and low trading prices of the Company's stock on the transaction date.

F3 · ownership.nature: The securities are held by the Christopher J. Twomey and Rebecca J. Twomey Family Trust UTD September 20, 2002.

SEC source: 0001438133-20-000044 · wf-form4_158896945165455.xml · nonDerivative · entry 1

TWOMEY CHRISTOPHER J · CIK 0001238935 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 45,000

F1 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2020.

F2 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $90.00 and $90.145. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

F3 · ownership.nature: The securities are held by the Christopher J. Twomey and Rebecca J. Twomey Family Trust UTD September 20, 2002.

SEC source: 0001438133-20-000042 · wf-form4_158863039667208.xml · derivative · entry 6

BERGER DAVID B · CIK 0001422126 · EVP, Chief Legal & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,000

Underlying: Stock Option · 2,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Fifty percent (50%) of the underlying shares subject to the option vested on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter.

F5 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

SEC source: 0001438133-20-000042 · wf-form4_158863039667208.xml · nonDerivative · entry 4

BERGER DAVID B · CIK 0001422126 · EVP, Chief Legal & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,311

F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2019.

SEC source: 0001438133-20-000042 · wf-form4_158863039667208.xml · nonDerivative · entry 3

BERGER DAVID B · CIK 0001422126 · EVP, Chief Legal & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,661

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares of common stock received upon exercise of a stock option award.

SEC source: 0001438133-20-000042 · wf-form4_158863039667208.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP, Chief Legal & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,311

F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2019.

SEC source: 0001438133-20-000042 · wf-form4_158863039667208.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP, Chief Legal & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,961

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares of common stock received upon exercise of a stock option award.

SEC source: 0001438133-20-000041 · wf-form4_158863033632595.xml · nonDerivative · entry 2

TWOMEY CHRISTOPHER J · CIK 0001238935 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 25,000

F1 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2020.

F2 · shares: The shares were originally purchased between 2008-2012 as Series B-Series D preferred stock.

F4 · ownership.nature: The securities are directly owned by Twomey Family Investments, LLC. The Reporting Person is co-manager of Twomey Family Investments, LLC and shares voting and investment power over the securities held by Twomey Family Investments, LLC and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such securities held by Twomey Family Investments, LLC, except to the extent of his proportionate pecuniary interest therein.

SEC source: 0001438133-20-000041 · wf-form4_158863033632595.xml · nonDerivative · entry 1

TWOMEY CHRISTOPHER J · CIK 0001238935 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 50,000

F1 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2020.

F2 · shares: The shares were originally purchased between 2008-2012 as Series B-Series D preferred stock.

F3 · ownership.nature: The securities are held by the Chris J. Twomey and Rebecca J. Twomey Family Trust UTD September 20, 2002.

SEC source: 0001438133-20-000028 · wf-form4_158637706817137.xml · derivative · entry 4

BERGER DAVID B · CIK 0001422126 · EVP, Chief Legal & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

Underlying: Stock Option · 2,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Fifty percent (50%) of the underlying shares subject to the option vested on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter.

F5 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

SEC source: 0001438133-20-000028 · wf-form4_158637706817137.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP, Chief Legal & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,311

F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2019.

SEC source: 0001438133-20-000028 · wf-form4_158637706817137.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP, Chief Legal & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,311

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares of common stock received upon exercise of a stock option award.

SEC source: 0001438133-20-000021 · wf-form4_158406348959369.xml · nonDerivative · entry 1

BLICKENSTAFF KIM D · CIK 0001238913 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 634,593

F1 · shares: The shares were given as a bona fide gift to BNGF KDB PEORIA WOMEN'S CLUB.

F2 · price: The price per share reflects the average of the high and low trading prices of the Company's stock on the transaction date.

F3 · ownership.nature: The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.

SEC source: 0001438133-20-000020 · wf-form4_158335853639616.xml · derivative · entry 4

BERGER DAVID B · CIK 0001422126 · EVP, Chief Legal & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,000

Underlying: Stock Option · 2,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Fifty percent (50%) of the underlying shares subject to the option vested on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter.

F6 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

SEC source: 0001438133-20-000020 · wf-form4_158335853639616.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP, Chief Legal & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,311

F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2019.

F3 · price: The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $76.95 to $77.56. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

SEC source: 0001438133-20-000020 · wf-form4_158335853639616.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP, Chief Legal & Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,311

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares of common stock received upon exercise of a stock option award.

SEC source: 0001438133-20-000019 · wf-form4_158293099576654.xml · derivative · entry 8

Allen Dick · CIK 0001582779 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 0

Underlying: Common Stock · 2,778 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.expiration_date: The expiration dates for this warrant are August 31, 2021 (1,356 shares), May 25, 2022 (596 shares) and July 17, 2022 (826 shares).

F3 · ownership.nature: The securities are held by the Allen Family Trust dated October 12, 1981.

SEC source: 0001438133-20-000019 · wf-form4_158293099576654.xml · derivative · entry 7

Allen Dick · CIK 0001582779 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 406 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.expiration_date: The expiration dates for this warrant are August 31, 2021 (271 shares) and July 3, 2022 (135 shares).

F2 · ownership.nature: The securities are held by Allen Cornerstone Ventures L.P. The Reporting Person is the managing partner of Allen Cornerstone Ventures L.P. and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by Allen Cornerstone Ventures L.P., except to the extent of his proportionate pecuniary interest therein.

SEC source: 0001438133-20-000019 · wf-form4_158293099576654.xml · nonDerivative · entry 4

Allen Dick · CIK 0001582779 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 37,179

F1 · kind: The transaction reflects the cashless exercise of warrants to purchase common stock, at an exercise price of $73.73. Pursuant to the terms of the warrant, the shares of common stock were sold at a price equal to the average of the closing prices of the shares over the 30-day period ending three days prior to the date on which the notice of exercise was received by the Issuer.

F3 · ownership.nature: The securities are held by the Allen Family Trust dated October 12, 1981.